International Business News - VPHM http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the stock activity stories for Friday, Nov. 21, from AP Financial News: CHARLOTTE, N.C. (AP)--KeyCorp shares tumbled Friday, as investors punished the regional bank for slashing its dividend for the second time in five months and continued to flee financial stocks amid concerns about the stability of the sector. http://www.ibtimes.com/articles/20081121/movers-roundup-keycorp-tivo.htm Fri, 21 Nov 2008 14:35:14 EST Oppenheimer & Co. started coverage on ViroPharma Inc. Friday with a "Perform" rating, taking a cautious position on the company over concern that competitors for its core products are closer to reaching the market. http://www.ibtimes.com/articles/20081121/oppenheimer-takes-cautious-view-on-viropharma.htm Fri, 21 Nov 2008 19:31:35 EST ViroPharma Inc. on Wednesday released new data on the effectiveness of its drug Cinryze against a hereditary disorder that causes dangerous swelling. ViroPharma plans to begin marketing Cinryze next month to treat hereditary angioedema, a protein deficiency that causes rapid swelling of the hands, feet and face. http://www.ibtimes.com/articles/20081112/viropharma-cites-positive-results-for-cinryze.htm Wed, 12 Nov 2008 16:48:59 EST Among the stock activity stories for Tuesday, Nov. 11, from AP Financial News: BOSTON (AP)--Shares of Genworth Financial Inc. sank to the stock's all-time low Tuesday, a day after Moody's Investors Service cut one of the insurance company's credit ratings and downgraded the financial strength of its life insurance subsidiary. http://www.ibtimes.com/articles/20081111/movers-roundup-genworth-viropharma.htm Tue, 11 Nov 2008 17:59:03 EST Among the stock activity stories for Tuesday, Nov. 11, from AP Financial News: NEW YORK (AP)--Shares of General Motors Corp. plunged to their lowest price since the days of World War II as investors continued to dump their shares amid panic that the automaker could be on the brink of collapse. http://www.ibtimes.com/articles/20081111/movers-roundup-general-motors-chesapeake-energy.htm Tue, 11 Nov 2008 15:04:21 EST Shares of ViroPharma Inc. dove Tuesday after likely rival Optimer Pharmaceuticals Inc. said patients taking its developing gastrointestinal infection drug had a higher cure rate and were less likely to relapse. http://www.ibtimes.com/articles/20081111/viropharma-shares-fall-on-rivals-study-data.htm Tue, 11 Nov 2008 16:24:15 EST Shares of Optimer Pharmaceuticals surged in premarket trading after the company said its developing gastrointestinal infection treatment was more effective than a potential competitor in a late-stage study. http://www.ibtimes.com/articles/20081111/ahead-of-the-bell-optimer-gains-ground-on-study.htm Tue, 11 Nov 2008 09:15:31 EST Among the stock activity stories for Wednesday, Oct. 29, from AP Financial News: NEW YORK (AP)--Shares in Johnson & Johnson fell 4 percent Wednesday after JPMorgan downgraded the stock, saying it is overvalued. http://www.ibtimes.com/articles/20081029/movers-roundup-johnson-johnson-verasun-energy.htm Wed, 29 Oct 2008 19:18:19 EDT Shares of ViroPharma Inc. jumped Wednesday after the drug maker reported a surge in third-quarter profit from sales of the gastrointestinal infection treatment Vancocin, and issued a positive full-year outlook. http://www.ibtimes.com/articles/20081029/viropharma-shares-rise-on-3q-profit-outlook.htm Wed, 29 Oct 2008 20:21:49 EDT Biopharmaceutical company ViroPharma Inc. forecast full-year sales for 2008 above Wall Street's expectations on Wednesday, after reporting that its earnings jumped 27 percent in the third quarter. http://www.ibtimes.com/articles/20081029/viropharmas-sales-outlook-tops-expectations.htm Wed, 29 Oct 2008 11:51:23 EDT ViroPharma Inc. said Wednesday that its earnings jumped 27 percent in the third quarter as sales of Vancocin, a treatment for gastrointestinal infection, surged and the biopharmaceutical company benefited from a lower tax rate. http://www.ibtimes.com/articles/20081029/viropharmas-3q-earnings-jump-on-vancocin-sales.htm Wed, 29 Oct 2008 11:49:47 EDT Biopharmaceutical company ViroPharma Inc. said Tuesday it completed the acquisition of Lev Pharmaceuticals. VioPharma said the deal allows it to broaden its portfolio of treatments by acquiring Lev's Cinryze, which treats angioedema, a swelling similar to hives but beneath, rather than on, the skin's surface. http://www.ibtimes.com/articles/20081021/viopharma-completes-buy-of-lev-pharmaceuticals.htm Tue, 21 Oct 2008 16:05:45 EDT ViroPharma Inc. said Monday it named Charles A. Rowland Jr. as chief financial officer, replacing Vincent J. Milano, who will continue as president and chief executive. http://www.ibtimes.com/articles/20081020/viropharma-names-new-chief-financial-officer.htm Mon, 20 Oct 2008 08:54:43 EDT ViroPharma Inc. said Wednesday that a federal regulatory period has expired, allowing the company to proceed with its buyout of Lev Pharmaceuticals Inc. http://www.ibtimes.com/articles/20080903/regulatory-review-of-viropharma-lev-tie-up-ends.htm Wed, 03 Sep 2008 10:11:20 EDT Among the stock activity stories for Wednesday, Aug. 13, from AP Financial News: LOS ANGELES (AP)--Shares in Warner Music Group Corp. slid 9.3 percent Wednesday after a filing showed top music executive Lyor Cohen sold 800,000 shares, more than a fifth of his stake in the company, earlier in the week. http://www.ibtimes.com/articles/20080813/movers-roundup-warner-music-viropharma.htm Wed, 13 Aug 2008 17:41:13 EDT ViroPharma Inc. shares passed a 52-week high in trading Wednesday, recovering to levels approached before the company's announcement last month of a deal to buy Lev Pharmaceuticals Inc. http://www.ibtimes.com/articles/20080813/shares-of-viropharma-pass-52-week-high.htm Wed, 13 Aug 2008 16:41:50 EDT Among the stock activity stories for Wednesday, July 16, from AP Financial News: NEW YORK (AP)--Shares of USANA Health Sciences Inc. tumbled Wednesday after a firm controlled by the company's chief executive ended its bid to buy the nutritional supplement and skin care products maker. http://www.ibtimes.com/articles/20080716/movers-roundup-usana-health-sciences-viropharma.htm Wed, 16 Jul 2008 19:10:08 EDT Among the stock activity stories for Wednesday, July 16, from the AP Financial Desk: NEW YORK (AP)_ Shares of Bellus Health Inc. gained Wednesday after the Canadian biotechnology company said it will buy privately-held Innodia Inc. for about $1.3 million, gaining development programs for diabetes and obesity therapies. http://www.ibtimes.com/articles/20080716/movers-roundup-bellus-health-viropharma.htm Wed, 16 Jul 2008 15:10:15 EDT ViroPharma Inc. shares wavered Wednesday as Wall Street took a second look at the company's buyout of Lev Pharmaceuticals and Lev's drug candidate Cinryze. http://www.ibtimes.com/articles/20080716/viropharma-rises-then-pares-gains-after-lev-deal.htm Wed, 16 Jul 2008 14:59:24 EDT ViroPharma Inc. shares wavered Wednesday as Wall Street took a second look at the company's buyout of Lev Pharmaceuticals and Lev's drug candidate Cinryze. http://www.ibtimes.com/articles/20080716/viropharma-rises-then-pares-gains-after-lev-deal.htm Wed, 16 Jul 2008 19:16:18 EDT